Work

Tagraxofusp and low-intensity chemotherapy for the treatment of CD123-positive relapsed or refractory Acute Myeloid Leukemia

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-8256

Authors: Woo In Cho, Ritika Dutta, Kyle Cobarrubias, Emily Inlow, Noel Adre, Nichole Olson, Kristen Cunanan, Vivek Charu, Asiri Ediriwickrema, Tian Zhang, Gabriel Mannis

Institutions: Stanford Cancer Institute, Stanford University, Stanford Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417014093

Cites:

Cited by:

Related to: